These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25431900)

  • 21. A novel SMARCAL1 missense mutation that affects splicing in a severely affected Schimke immunoosseous dysplasia patient.
    Barraza-García J; Rivera-Pedroza CI; Belinchón A; Fernández-Camblor C; Valenciano-Fuente B; Lapunzina P; Heath KE
    Eur J Med Genet; 2016 Aug; 59(8):363-6. PubMed ID: 27282802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased Wnt and Notch signaling: a clue to the renal disease in Schimke immuno-osseous dysplasia?
    Morimoto M; Myung C; Beirnes K; Choi K; Asakura Y; Bokenkamp A; Bonneau D; Brugnara M; Charrow J; Colin E; Davis A; Deschenes G; Gentile M; Giordano M; Gormley AK; Govender R; Joseph M; Keller K; Lerut E; Levtchenko E; Massella L; Mayfield C; Najafian B; Parham D; Spranger J; Stenzel P; Yis U; Yu Z; Zonana J; Hendson G; Boerkoel CF
    Orphanet J Rare Dis; 2016 Nov; 11(1):149. PubMed ID: 27816064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Schimke Immunoosseous Dysplasia associated with undifferentiated carcinoma and a novel SMARCAL1 mutation in a child.
    Carroll C; Badu-Nkansah A; Hunley T; Baradaran-Heravi A; Cortez D; Frangoul H
    Pediatr Blood Cancer; 2013 Sep; 60(9):E88-90. PubMed ID: 23630135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dental abnormalities in Schimke immuno-osseous dysplasia.
    Morimoto M; Kérourédan O; Gendronneau M; Shuen C; Baradaran-Heravi A; Asakura Y; Basiratnia M; Bogdanovic R; Bonneau D; Buck A; Charrow J; Cochat P; Dehaai KA; Fenkçi MS; Frange P; Fründ S; Fryssira H; Keller K; Kirmani S; Kobelka C; Kohler K; Lewis DB; Massella L; McLeod DR; Milford DV; Nobili F; Olney AH; Semerci CN; Stajic N; Stein A; Taque S; Zonana J; Lücke T; Hendson G; Bonnaure-Mallet M; Boerkoel CF
    J Dent Res; 2012 Jul; 91(7 Suppl):29S-37S. PubMed ID: 22699664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Schimke immunoosseous dysplasia and management considerations for vascular risks.
    Beleford DT; Diab M; Qubty WF; Malloy MJ; Long RK; Shieh JT
    Am J Med Genet A; 2019 Jul; 179(7):1246-1252. PubMed ID: 31039288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutaneous squamous cell carcinoma with epidermodysplasia verruciformis-like features in a patient with Schimke immune-osseous dysplasia.
    Collins MK; Peters K; English JC; Rady P; Tyring S; Jedrych J
    J Cutan Pathol; 2018 Jun; 45(6):465-467. PubMed ID: 29498428
    [No Abstract]   [Full Text] [Related]  

  • 27. Dental abnormalities and preventive oral care in Schimke immuno-osseous dysplasia.
    Gendronneau M; Kérourédan O; Taque S; Sixou JL; Bonnaure-Mallet M
    Eur Arch Paediatr Dent; 2014 Jun; 15(3):217-21. PubMed ID: 24327104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Membranous nephropathy in Schimke immuno-osseous dysplasia.
    Ozdemir N; Alpay H; Bereket A; Bereket G; Biyikli N; Aydoğan M; Cakalağoğlu F; Kiliçaslan I; Akpinar I
    Pediatr Nephrol; 2006 Jun; 21(6):870-2. PubMed ID: 16570201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Manifestations and treatment of Schimke immuno-osseous dysplasia: 14 new cases and a review of the literature.
    Boerkoel CF; O'Neill S; André JL; Benke PJ; Bogdanovíć R; Bulla M; Burguet A; Cockfield S; Cordeiro I; Ehrich JH; Fründ S; Geary DF; Ieshima A; Illies F; Joseph MW; Kaitila I; Lama G; Leheup B; Ludman MD; McLeod DR; Medeira A; Milford DV; Ormälä T; Rener-Primec Z; Santava A; Santos HG; Schmidt B; Smith GC; Spranger J; Zupancic N; Weksberg R
    Eur J Pediatr; 2000; 159(1-2):1-7. PubMed ID: 10653321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone marrow transplantation in Schimke immuno-osseous dysplasia.
    Baradaran-Heravi A; Lange J; Asakura Y; Cochat P; Massella L; Boerkoel CF
    Am J Med Genet A; 2013 Oct; 161A(10):2609-13. PubMed ID: 23950031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Schimke versus non-Schimke chronic kidney disease: an anthropometric approach.
    Lücke T; Franke D; Clewing JM; Boerkoel CF; Ehrich JH; Das AM; Zivicnjak M
    Pediatrics; 2006 Aug; 118(2):e400-7. PubMed ID: 16816006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different Phenotypes of Schimke Immuno-Osseous Dysplasia (SIOD) in Two Sisters with the Same Mutation in the SMARCAL1 Gene.
    Castellano-Martinez A; Acuñas-Soto S; Varga-Martinez R; Rodriguez-Gonzalez M; Mora-Lopez F; Iriarte-Gahete M; Roldan-Cano V
    Endocr Metab Immune Disord Drug Targets; 2022; 22(8):888-894. PubMed ID: 35209826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Schimke immuno-osseous dysplasia.
    Basiratnia M; Fallahzadeh MH
    Saudi Med J; 2007 Mar; 28(3):457-60. PubMed ID: 17334480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Schimke immunoosseous dysplasia: an ultra-rare disease. a 20-year case series from the tertiary hospital in the Czech Republic.
    Zieg J; Bezdíčka M; Němčíková M; Balaščáková M; Suková M; Štěrbová K; Vondrák K; Dušek J; Křepelová A
    Ital J Pediatr; 2023 Jan; 49(1):11. PubMed ID: 36658659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generalized atherosclerosis sparing the transplanted kidney in Schimke disease.
    Lücke T; Marwedel KM; Kanzelmeyer NK; Hori A; Offner G; Kreipe HH; Ehrich JH; Das AM
    Pediatr Nephrol; 2004 Jun; 19(6):672-5. PubMed ID: 15054643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eltrombopag (thrombopoietin-receptor agonist) and plasmapheresis as rescue therapy of acute post-renal transplant immune thrombocytopenia in a child with Schimke immuno-osseous dysplasia-case report.
    Grenda R; Jarmużek W; Latoszyńska J; Prokurat S; Rubik J
    Pediatr Transplant; 2016 Dec; 20(8):1148-1151. PubMed ID: 27671102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel SMARCAL1 bi-allelic mutations associated with a chromosomal breakage phenotype in a severe SIOD patient.
    Simon AJ; Lev A; Jeison M; Borochowitz ZU; Korn D; Lerenthal Y; Somech R
    J Clin Immunol; 2014 Jan; 34(1):76-83. PubMed ID: 24197801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of IL7Rα expression in T cells is a hallmark of T-cell immunodeficiency in Schimke immuno-osseous dysplasia (SIOD).
    Sanyal M; Morimoto M; Baradaran-Heravi A; Choi K; Kambham N; Jensen K; Dutt S; Dionis-Petersen KY; Liu LX; Felix K; Mayfield C; Dekel B; Bokenkamp A; Fryssira H; Guillen-Navarro E; Lama G; Brugnara M; Lücke T; Olney AH; Hunley TE; Polat AI; Yis U; Bogdanovic R; Mitrovic K; Berry S; Najera L; Najafian B; Gentile M; Nur Semerci C; Tsimaratos M; Lewis DB; Boerkoel CF
    Clin Immunol; 2015 Dec; 161(2):355-65. PubMed ID: 26499378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chromatin changes in SMARCAL1 deficiency: A hypothesis for the gene expression alterations of Schimke immuno-osseous dysplasia.
    Morimoto M; Choi K; Boerkoel CF; Cho KS
    Nucleus; 2016 Nov; 7(6):560-571. PubMed ID: 27813696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fatal lymphoproliferative disorder in a child with Schimke immuno-osseous dysplasia.
    Taha D; Boerkoel CF; Balfe JW; Khalifah M; Sloan EA; Barbar M; Haider A; Kanaan H
    Am J Med Genet A; 2004 Dec; 131(2):194-9. PubMed ID: 15523612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.